Clinical trial
Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm…
NCT00331695 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00331695 |
|---|---|
| Title | Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery |
| Official title | Evaluation of the Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Preterm Delivery |
| Intervention type | Drug |
| Interventions | 17 alpha-hydroxyprogesterones caproate |
| Enrollment | 560 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | May 31, 2006 |
| Last update posted | May 9, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: